Additional information
White Powder
2226413-62-1
ACI-180616
(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-[(1E)-2-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-N-methylethene-1-sulfonamido]-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid sodium
S-Demethyl (E)-S-[4-(4-Fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-ethenyl Rosuvastatin Sodium Salt
218.5-220.5°C
C38H43F2N6NaO8S2
836.9
Ambient
2-8°C
HMG-CoA reductase inhibitor





![BUTOXYQUINOLINONE BREXPIPRAZOLE (25 mg) (7-[4-(7-{4-[4-(Benzo[b]thiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2-yloxy)butoxy]quinolin-2(1H)-one)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)